Recombinant Human LOX1 Protein，His

LOX1, or lectin-like oxidized low-density lipoprotein receptor 1, is a crucial protein involved in lipid metabolism and atherosclerosis. As a pattern recognition receptor, LOX1 binds to oxidized low-density lipoproteins (oxLDL), initiating a cascade of cellular events that contribute to the pathogenesis of cardiovascular diseases. The receptor is predominantly expressed in endothelial cells, macrophages, and smooth muscle cells, where it plays a significant role in the development of foam cells and vascular inflammation. The study of recombinant LOX1 proteins has garnered significant attention due to their potential utility in understanding the receptor's structure-function relationship and in the development of therapeutic strategies targeting cardiovascular diseases. By engineering LOX1 proteins, researchers aim to elucidate the molecular mechanisms underlying its interactions with oxLDL and to investigate its role in inflammation and cellular signaling pathways. Moreover, recombinant LOX1 proteins serve as valuable tools for drug discovery, enabling the identification of small molecules or antibodies that can modulate its activity. The exploration of LOX1 as a biomarker for atherosclerosis and cardiovascular risk further emphasizes the importance of this receptor in clinical research. Overall, the investigation of LOX1 recombinant proteins is expected to provide critical insights into the mechanisms of cardiovascular diseases and to pave the way for novel therapeutic approaches aimed at reducing the burden of atherosclerosis and its associated complications.